Canadian Doctor Assaulted Wife In Hamilton

The incident took place in Hamilton. The assault with intent charge related to Ishwarlall headbutting her. Ishwarlall was due to be sentenced in court today, but his lawyer David Allan was successful in having it delayed nine months so his client could complete rehabilitative courses and treatments. Allan also applied for a discharge without conviction. However, Judge Tompkins will not make a decision on that until next year – but did hint that it’s unlikely to be successful. Ishwarlall, originally from South Africa, will now head back to Canada – to his wife and son – and will have regular treatments with his New Zealand-based psychologist via Skype. Allan said convictions would affect his ability work as an anaesthesiologist at Moose Jaw Union Hospital at Saskatchewan, Canada. A probation report showed Ishwarlall’s wife was ready to give him another chance if he completed treatment programmes. Allan told Judge Tompkins he accepted his proposal and Ishwarlall’s circumstances “were quite exceptional” however his client had already taken a month’s extra leave from his job and he was keen to get back. A psychologist report revealed a history of domestic violence with his wife, which was revealed to be a result of Ishwarlall’s upbringing and violence between his parents. Judge Tompkins said given Ishwarlall was in New Zealand on holiday his sentencing options were limited and he was reluctant to send him to prison.

secret info http://www.stuff.co.nz/waikato-times/news/9163122/Canadian-doctor-assaulted-wife-in-Hamilton

Canadian doctors still make dramatically less than U.S. counterparts: study

But Dr. Haggie voiced no particular envy Tuesday at the statistics just published in the journal Health Affairs , saying that factors other than money influence where doctors settle, including for some the appeal of Canadas universal, government-funded health system. A good salary package is an attractor, its a magnet but it doesnt always have the same effect at the other end when youre trying to retain people, said Dr. Haggie. The system in which (physicians) work is part of the attraction of working here. That migration to the U.S. has reversed in the last few years, with a small net influx of MDs from south of the border as incomes rose here, according to statistics and the accounts of medical recruitment agencies. The new studys authors, both health policy professors at New Yorks Columbia University, did the research to help detail why the cost of health care is so steep in the U.S. compared to other countries. It may partly reflect an American society where the mostly highly educated and skilled people in all fields tend to earn a bigger chunk of the overall wealth than similar groups in other countries, Miriam Laugesen, the lead researcher, said in an interview. Regardless, the 2008 figures that Prof. Laugesen and her colleague gathered offer a fascinating glimpse at the profession in six countries, with stark differences in payment between nations, and between private and public payors in those places that have two-tier systems. The average income after expenses, in U.S. dollars, for an orthopedic surgeon in the U.S. was $442,450, compared to $208,000 in Canada, $324,000 in the U.K. and $154,000 in France.

how much is yours worth http://news.nationalpost.com/2011/09/14/canadian-doctors-still-make-dramatically-less-than-u-s-counterparts-study/

First National Guidelines Published For Endoscopy Services In Canada

Recommendations were endorsed if more than 80 per cent of experts agreed with the statement (consensus). In recent years, the volume of endoscopic procedures in Canada, such as colonoscopies, has been increasing and demand is exceeding supply. In response, over the past decade the CAG has developed and implemented a number of programs to promote greater safety and quality in endoscopic services. For example, Canada has adopted the Global Rating Scale (GRS), a web-based endoscopy evaluation tool that evaluates multiple components of endoscopy service from a patient-focused perspective. The Consensus Guidelines – in the making for three years – is a natural extension of the GRS and related programs that support the CAG’s commitment to safe, high-quality patient-centered care. “Now that the guidelines are in place, we will work with our members, our partners, provincial gastroenterology associations and other stakeholders to promote their broad implementation across Canada,” said Dr. David Morgan, President of the CAG. “The CAG is committed to provide those who deliver endoscopic services with tools they need to ensure patient-centered, quality service in their day-to-day practice”. Download an executive summary of The Canadian Association of Gastroenterology Consensus Guidelines on Safety and Quality Indicators in Endoscopy . Copies of the full report are available upon request. (i)Endoscopy involves examining the inside of a person’s body using an endoscope – a long, thin tube with a light and camera attached to it.

her comment is here http://finance.yahoo.com/news/first-national-guidelines-published-endoscopy-130000280.html

Gastroenterologists release new safety guidelines

In this Oct. 3, 2007, file photo released by the University of Wisconsin Medical School shows a virtual colonoscopy, a 3-D image that was computer-generated from a series of X-rays taken by a CT scanner. (AP Photo/ Courtesy of Dr. Perry J. Pickhardt/ University of Wisconsin Medical School, file)

– Canada’s gastroenterologists have new guidelines on safety and quality indicators to help with the more than 1.6 million procedures performed each year, their association announced Monday. Although the Canadian Association of Gastroenterology has guidelines around credentials and training, there was a void in other areas. “If one looks at the sort of totality of endoscopy service delivery, particularly from a patient point of view — which is access to services, rapid access, high quality services, feedback, and an ability to respond to how they perceive endoscopy service delivery — then there really was nothing in place,” said Dr. David Armstrong, chair of the endoscopy committee and the consensus guideline committee. Endoscopy is used to detect or screen for a number of diseases and involves examining the colon or digestive tract using a long, thin tube with a light and camera attached. Last October, about 6,800 Ottawa residents were sent letters from public health officials after it was found that a non-hospital clinic wasn’t following some procedures involving cleaning and infection prevention. The letters indicated the patients might have been exposed to hepatitis B, hepatitis C or HIV. Armstrong said he likes to think the presence of these guidelines would have made a difference in the Ottawa situation. “That’s really because one of the challenges for endoscopy — and it’s in and out of hospitals — has been that if there isn’t a framework to say how things should be monitored and how they should be delivered, it’s difficult to know how much or how closely to monitor things, and what actually are the standards,” Armstrong said in an interview from Hamilton, where he’s an associate professor of medicine at McMaster University. “So I think guidelines that say what should be monitored and what processes have to be in place really from a patient point of view and knowledge that there are tools available to monitor the way that services are delivered and to use as a basis for quality improvement programs would have made a big difference.” Armstrong indicated that it used to be felt that washing the scope and then doing a manual cleaning was sufficient. “And the trouble is there are times when that isn’t sufficient.

her explanation http://www.ctvnews.ca/gastroenterologists-release-new-safety-guidelines-1.758456

Endoscopist specialty is associated with colonoscopy quality

However, despite statistical adjustment, residual confounding due to patient-level risk factors may contribute the observed difference between specialties. Several prior studies have examined the association between endoscopist speciality and missed CRCs. In a retrospective cohort study using population level data from Ontario, Bressler et al. identified endoscopist specialty as a risk factor for incident CRCs post-colonoscopy among both male and female patients [ 16 ]. In contrast to our study, the difference was found mainly between gastroenterologists and primary care physicians, rather than between gastroenterologists and surgeons. This study also found that office colonoscopies are more likely to be associated with missed lesions than hospital-based colonoscopies. A Manitoba study also showed no difference in missed cancers between surgeons and gastroenterologists. This model included colonoscopy volume and practice location (rural vs. urban) as covariates, neither of which was significantly associated with missed cancers [ 18 ]. Rabeneck et al. reported an odds ratio of 1.39 (95% CI: 1.161.67) for the risk of CRC diagnosis after negative colonoscopy in the patients seen by surgeons vs.

navigate to this web-site http://www.biomedcentral.com/1471-230X/13/78

Sports Medicine Specialist Tim Rindlisbacher M.d. Named Head Team Physician For Toronto Argonauts Football Club

Michael’s Hospital – Toronto’s downtown trauma centre. Toronto Argonauts Head Athletic Therapist Dave Wright commented, “We are very pleased to have a renowned sports physician caring for our players and coaches. Dr. Rindlisbacher is a trusted sports health professional who will play a pivotal role within the Argonauts’ medical staff. We look forward to working with Dr. Rindlisbacher in keeping our players healthy and on the field so that they can be ready to play at their best and win another Grey Cup title for Toronto.” More information about Cleveland Clinic Canada is available online at http://www.clevelandclinic.ca . Further information about the Toronto Argonauts Football Club is available at http://www.argonauts.ca . About Sports Health at Cleveland Clinic Canada Cleveland Clinic Canada’s comprehensive Sports Health Program is designed to meet the medical, nutritional and fitness needs of recreational and professional athletes, as well as individuals who experience muscle and joint pain. Their experts work to enhance both performance and health-related fitness for recreational and elite athletes. The multidisciplinary team includes Sports and Exercise Medicine specialists, Orthopedic Surgeons, Sports/Orthopedic Physiotherapists, Chiropractors, Osteopaths, Registered Massage Therapists, Exercise Physiologists, and Registered Sports Dieticians. Cleveland Clinic Canadaspecialistsalso hold credentials withmany of Toronto’s teaching hospitals, including Women’s College Hospital, Sunnybrook Health Sciences Centre, and St.

weblink http://www.newswire.ca/en/story/1214163/sports-medicine-specialist-tim-rindlisbacher-m-d-named-head-team-physician-for-toronto-argonauts-football-club

The Canadian medical profession is facing major upheaval

Patients (and payers) are demanding more patient- and family-centred care and a lot less paternalism. Care is shifting out of hospitals, the traditional power base for specialist physicians, and into the community. The traditional family physician in solo practice is disappearing and being replaced by clinics staffed by multidisciplinary teams. (Where doctors will still play an essential role, lets not forget.) Along with the recognition that the sands are shifting is a fair bit of grumbling, especially from older docs (there is a striking generation gap in the practice of medicine that is rarely talked about). Dr. Francescutti told his colleagues to embrace rather than resist change, for the good of patients. He even urged them to consider some radical ideas. Wouldnt it be great if there were no patients? the CMA president said. We need to have that conversation. By this, he means that physicians should not just sit back and treat disease; they have to put much more effort into prevention and, in particular, use their influence to get governments and the public to address the root causes of disease, the so-called socio-economic determinants of health. (His predecessor as CMA president, Anna Reid, also made this her rallying cry.) That means advocating for early childhood education, social housing, decent wages and the like, not just more health spending. Dr. Francescutti referred, at length, to the wake-up call to the profession delivered last year by Governor-General David Johnston. In a memorable speech to the Royal College of Physicians and Surgeons, Mr. Johnston reminded doctors that they are a party to a social contract, one that grants them status and privilege, but in return entails an obligation to serve the public good. In 2013, the public good requires that Canadian physicians embrace a fundamental transformation of the health system and that they advocate passionately for the changes patient-centred care, a shift to the community and tackling social inequities even if they will, as a profession, pay a price for doing so.

the best http://www.theglobeandmail.com/life/health-and-fitness/health/the-canadian-medical-profession-is-facing-major-upheaval/article13941175/

Australian Budget Spares Research From Further Blow

Australian Gastroenterology Week (AGW) 2007 & Developments in Ulcerative Colitis

The govermnent has yet to calculate the final tally for all the research-related items in its budget, according to a departmental spokesperson. So it is unclear yet whether total funding levels for for 201314 will be higher or lower than those for 201213. Science and Technology Australia, a professional-interests group in Canberra that represents 68,000 scientists and technologists, said in a statement that the budget holds little for science and technology with a reprieve for mid-career fellowships and critical infrastructure funding but scant long-term vision. The Australian Academy of Science agrees. While the academy welcomes short-term investments in researchers and research infrastructure, this budget unfortunately represents a missed opportunity to support a strategic long-term vision for Australias future, academy president Suzanne Cory said in a statement. The science community had steeled itself for a new blow after the governments announcement on 13 April of a Aus$2.3-billion (US$2.27-billion) cut to some university research, teaching and learning grants and student-support schemes. The cuts came after the governments decision last October to delay planned increases to the Sustainable Research Excellence scheme, which covers part of the indirect costs of university research, such as maintenance and technical support. Budget shortfall The Labor party, which holds a minority government with the support of the Australian Greens and some independents, revealed last week that national revenue had been Aus$17 billion lower than expected in the 201213 financial year. But the government reaffirmed its commitment to major initiatives a school reform programme and a national disability-insurance scheme. With a federal election looming in September, the government had been under pressure to put the budget on the road to a future surplus. On Tuesday, the government reported that the deficit in 201314 will be Aus$18 billion, down from Aus$19.4 billion in 201213, with the budget expected to return to balance in 201516 and to surplus in 201617. In the budget, the government resurrected the National Collaborative Research Infrastructure Strategy, allocating Aus$185.9 million over two years to keep vital research facilities running. Scientists had worried about the fate of infrastructure worth hundreds of millions of dollars, such as the Australian Plasma Fusion Research Facility at the Australian National University (ANU) in Canberra. The government also laid out a little more than Aus$135 million over five years to extend the Australian Research Councils Future Fellowships scheme, a programme to attract and retain outstanding mid-career researchers.

more things http://www.nature.com/news/australian-budget-spares-research-from-further-blow-1.12993

Levels of 5-ASA in the lining of the bowels have been shown to predict efficacy and possibly act as a marker for clinical endpoints in patients with disease. A clinical trial was performed by Haines et al, to try and determine a simple, yet sensitive and reproducible method for detection of 5-ASA in the lining of the bowel. Specific concentrations of 5-ASA were added to biopsies (tissue samples) of the lining of the colon. From the study, clear, reproducible peaks were achieved at certain wavelengths. These peaks were significantly sensitive for 5-ASA. What we need to do now is to apply these results in a clinical context. Genes Implicated in IBD – IL23R is an IBD Susceptibility Gene (confirmation in an Australian cohort) and GLI1 gene a Risk Factor for Ulcerative Colitis With advances in research and from results of clinical studies, additional insight into the causes and genetics behind ulcerative colitis has been obtained. For example, variations in particular receptors such as the IL 23 receptor has recently been shown to be associated with both Crohn’s and ulcerative colitis. Another gene called the GLI1 gene plays a significant role in the formation and maintenance of a healthy lining for our gut. Defects in the GLI1 gene have been implicated in patients with ulcerative colitis. Patterns of Medication use in Inflammatory Bowel Disease PatientsThere is a wide range of therapies for ulcerative colitis – depending on the location of disease, different combinations of treatments are employed. In disease limited to the rectum, the mainstay of therapy includes topical aminosalicyclate (5-ASA) suppositories (small masses of medication that are designed to melt when inserted into a body cavity). Topical therapy refers to local application of treatment directly onto the surface of a body part. In more extensive cases where disease affects larger parts of the bowels, combination therapy involving 5-ASA agents (both oral and topical), steroids and other immunosuppressive agents is recommended. In a recent study conducted by Barclay et al, an increased use of medications which act to alter the immune response (immunomodulators) was demonstrated. Out of 1421 patients with inflammatory bowel disease, the use of immunomodulators including azathioprine, 6 mercaptopurine and methotrexate was investigated.

visite site http://www.virtualmedicalcentre.com/news/australian-gastroenterology-week-agw-2007-and-developments-in-ulcerative-colitis/10803

Salem Gastroenterology Practice Closes, But Doctors Stay In Area

Vote now in this year’s Best Of Holiday Shopping readers’ choice poll. Salem gastroenterology practice closes, but doctors stay in area Laurence Hammack | 981-3239 Saturday, September 7, 2013 An independent gastroenterology practice in Salem has closed, with four of its physicians joining Carilion Clinic and two going to LewisGale Physicians. Carilion announced Friday that Valley Gastroenterology of Southwest Virginia was joining Carilion Clinic Gastroenterology. The four physicians from the Salem clinic will nearly double the size of Carilions practice, the Roanoke-based health care system said in a news release. However, two of the six doctors at the former Valley Gastroenterology are in the process of joining LewisGale, a spokeswoman for the Salem health care system said. The moves come at a time of growing demand in the Roanoke Valley for gastroenterology services, which include the treatment of digestive disorders such as heartburn, acid reflux, ulcers and inflammatory bowel diseases. Carilions news release quoted Dr. Robert Moylan, previously of Valley Gastroenterology, who could not be reached Friday. Carilions expanding role as a medical center and teaching facility makes this an excellent choice for us, Moylan was quoted as saying. But LewisGale is also gaining new positions and expanding its services. Our gastroenterology program is robust and its still growing, LewisGale spokeswoman Joy Sutton said. Saturday, September 7, 2013

click over here now http://www.roanoke.com/news/business/2207314-12/salem-gastroenterology-practice-closes-but-doctors-stay-in.html

Audio-Digest Foundation Announces the Release of Gastroenterology Volume 27, Issue 11: Celiac Disease

Analyze the histologic findings associated with CD 4. Implement genetic and serologic testing for CD 5. Formulate a multidisciplinary management plan for patients diagnosed with CD The original programs were presented by Dora M. Lam-Himlin, MD, Assistant Professor of Pathology and Senior Associate Consultant, Mayo Clinic, Arizona, Phoenix, and Joseph A. Murray, MD, Professor of Medicine, Consultant, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN. Audio-Digest Foundation, the largest independent publisher of Continuing Medical Education in the world, records over 10,000 hours of lectures every year in anesthesiology, emergency medicine, family practice, gastroenterology, general surgery, internal medicine, neurology, obstetrics/gynecology, oncology, ophthalmology, orthopaedics, otolaryngology, pediatrics, psychology, and urology, by the leading medical researchers at the top laboratories, universities, and institutions. Recent researchers have hailed from Harvard, Cedars-Sinai, Mayo Clinic, UCSF, The University of Chicago Pritzker School of Medicine, The University of Kansas Medical Center, The University of California, San Diego, The University of Wisconsin School of Medicine, The University of California, San Francisco, School of Medicine, Johns Hopkins University School of Medicine, and many others. Out of these cutting-edge programs, Audio-Digest then chooses the most clinically relevant, edits them for clarity, and publishes them either every week or every two weeks. In addition, Audio-Digest publishes subscription series in conjunction with leading medical societies: DiabetesInsight with The American Diabetes Association, ACCEL with The American College of Cardiology, Continuum Audio with The American Academy of Neurology, and Journal Watch Audio General Medicine with Massachusetts Medical Society. For 60 years, the global medical community of doctors, nurses, physician assistants, and other medical professionals around the world has subscribed to Audio-Digest specialty series in order to remain current in their specialties as well as to maintain their Continuing Education requirements with the most cutting-edge, independent, and unbiased continuing medical education (CME). Long a technical innovator, Audio-Digest was the first to produce audio medical education programs and the first to produce in-car medical education.

navigate to this website http://www.consumerelectronicsnet.com/article/Audio-Digest-Foundation-Announces-the-Release-of-Gastroenterology-Volume-27-Issue-11:-Celiac-Disease-2787440

My Patient Has a Large Pancreatic Cyst. Should I Involve a Surgeon in the Evaluation and Management of This Situation?

Pancreatic tail cyst as seen through the mesentery

Pancreatic tail cyst as seen through the mesentery. Figure 29-2. Specimen of resection leading to splenectomy due to infiltration of the splenic vein by the cystic mass. Cysts located in the head of the pancreas are resected with standard or pylorus-preserving pancreaticoduodenectomy. Patients presenting with pain or jaundice warrant resection. For the asymptomatic patient, investigation is similar to that for the asymptomatic lesion of the body/tail described above. For patients found to have mucinous cysts of the head of the pancreas, I feel that pylorus preservation provides better gastric function and long-term quality of life without infringing on the oncologic principles of the resection. For the rare cyst of the neck of the pancreas, a central pancreatectomy may be employed as the procedure for cyst excision. The benefits of central pancreatectomy focus on pancreatic parenchymal preservation. Caution must be used when recommending and performing central pancreatectomy. First, it is of utmost importance to ensure the benign or low malignant potential nature of the lesion due to the oncologic limitations of central pancreatectomy. Second, several high-volume pancreatic centers have documented a high morbidity rate associated with central pancreatectomy. I feel that only experienced pancreatic surgeons at high-volume centers should be involved in the selection and care of these unique patients. The decision to operate on a tail or head cyst is multifactorial and must account for patient-presenting symptoms, CT and EUS findings, and cyst fluid analysis. In my mind, I do not necessarily change my diagnostic algorithm based on cyst location alone. At high-volume centers, pancreaticoduodenectomy and distal pancreatectomy are able to be performed with very low morbidity and mortality rates.

browse this site http://www.healio.com/gastroenterology/curbside-consultation/{40723dd0-cb01-4ada-a31f-c79788dafa54}/my-patient-has-a-large-p

Klaus Schiller: Pioneering Physician And Gastroenterologist

Come fly with me: How Dirk Bogarde’s great-niece became pop’s brightest young star... Birdy

Klaus Schiller was born in Vienna in 1927 to Walter, a gynaecologist, and Berta, the daughter of an industrialist. Following the Anschluss in 1938, his comfortable childhood was interrupted by enforced emigration and he was sent, with his sister, Verena, to England. Within a few days and with hardly a word of English, he found himself at boarding school in Bishop’s Stortford. He always denied that this uprooting was traumatic and agreed with his friend, the late Professor Peter Scheuer, that “the best thing that ever happened to us was to come to England.” Klaus’s parents and grandparents soon followed and he was sent to Clifton College. In 1945 he gained an Exhibition to read medicine at Queen’s College, Oxford a city that was important to him throughout his life. In 1948, he won a scholarship to the London Hospital, completing his clinical training in December 1951. He was appointed to two house officer posts at the London, and served two years national service, mostly as a medical specialist. After a clutch of junior positions elsewhere, he returned to the London as a registrar. He was appointed senior registrar at the Radcliffe Infirmary in 1962 and in 1966 received his doctorate. Eager to become a consultant, he spent a happy year at the Massachusetts General Hospital. Returning to Oxford, Dr Schiller worked with his mentor and lifelong friend Dr Sidney Truelove. They undertook an in-depth survey of haematemesis and melaena, and the risky abdominal surgical interventions that were undertaken as a result.

reference http://www.independent.co.uk/news/obituaries/klaus-schiller-pioneering–physician-and-gastroenterologist-2041049.html

Decision Resources: 68% of gastroenterologists select Remicade for Crohn’s treatment

Physicians’ favorable opinion of Remicade’s efficacy for treating moderate to severe Crohn’s disease and the drug’s higher price compared with Crohn’s disease therapies for which generic versions are available, such as prednisone and azathioprine, contribute to Remicade’s status as the current sales leader in this market. Decision Resources’ analysis of the Crohn’s disease drug market reveals that surveyed physicians who regard Remicade as the most efficacious therapy were most satisfied with the drug’s efficacy in induction of remission and response and its impact on quality of life. However, they were least satisfied with Remicade’s effect on maintenance of remission, corticosteroid-free remission, and response, presumably because of patients’ tendency to lose response to the drug over time. In contrast to surveyed gastroenterologists, the majority (60 percent) of surveyed managed care organizations’ (MCOs) pharmacy directors selected Abbott/Eisai’s Humira (adalimumab) as the most efficacious therapy for Crohn’s disease. Surveyed payers who selected Humira as the most efficacious therapy were most satisfied with the drug’s induction and maintenance of remission and response. The findings also reveal that surveyed gastroenterologists who selected Humira as most efficacious were most satisfied with its ability to improve patients’ quality of life. “Although only 23 percent of surveyed gastroenterologists chose Humira as the most efficacious therapy for Crohn’s disease, these physicians expressed a high level of satisfaction with Humira’s impact on quality of life and its effect on maintenance of remission, which will likely contribute to Humira’s increased use in the maintenance setting,” said Decision Resources Analyst MaryEllen Klusacek, Ph.D. “Considering all assessed efficacy end points, surveyed gastroenterologists were least satisfied with Humira’s effect on mucosal healing and fistula closure.” The findings also reveal that the Crohn’s disease drug market will experience modest growth over the next decade, increasing from approximately $3.2 billion in 2009 to $4.2 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. This moderate growth rate will mask dramatic changes as market growth from newer and emerging biological agents outpaces the decline in sales of older, established agents, which will face increasing generics competition and declining use. Tumor necrosis factor-alpha (TNF-alpha) inhibitors, namely Remicade and Humira, dominated the market in 2009, capturing nearly 77 percent of major-market sales. Additionally, several therapies with novel mechanisms of action are expected to launch for Crohn’s disease beginning in 2013, including Millennium Pharmaceuticals’ vedolizumab, Centocor Ortho Biotech/Janssen-Cilag’s Stelara (ustekinumab) and GlaxoSmithKline/ChemoCentryx’s GSK-1605786 (formerly CCX-282B or Traficet-EN). However, none of these agents will rival the efficacy or market share of the TNF-alpha inhibitors. Source: Decision Resources, Inc.

my company http://www.news-medical.net/news/20110324/Decision-Resources-6825-of-gastroenterologists-select-Remicade-for-Crohns-treatment.aspx

Sunscreen Prevents Skin Cancer, Yet Doctors Rarely Recommend It

Doctors resign from UC Davis after getting caught infecting cancer patients’ brains with fecal bacteria

Nope. The American Academy of Dermatology , the American Academy of Pediatrics , the American College of Gynecologists and the American Academy of Family Physicians all advise their members to counsel patients on protecting themselves from the sun. The Centers for Disease Control and Prevention and the American Cancer Society also endorse the practice. And yet, when researchers from the Center for Dermatology Research at Wake Forest School of Medicine in North Carolina examined data from the CDCs National Ambulatory Medical Care Survey , they found that dermatologists mentioned sunscreen in only 1.6% of patient visits. When seeing patients with skin cancer or a history of the disease, sunscreen came up only 11.2% of the time. And dermatologists are the ones who are experts on keeping skin healthy. Family medicine doctors and general practitioners discussed sunscreen only 0.03% of the time; internal medicine doctors did so 0.01% of the time; and pediatricians did so 0.01% of the time. All other doctors advised sunscreen use in 0.002% of patient visits. One of the things that the researchers found most troubling was the fact that children (and their parents) were so rarely advised to use sunscreen. When they analyzed the data by age group, the researchers found that children under 10 were the least likely to be counseled about sunscreen use. Children and adolescents get the most sun exposure of any age group, as they tend to spend much of their time playing outdoors, the study authors noted in their report , published online Wednesday by JAMA Dermatology. Up to 80% of sun damage is thought to occur before age 21 years, and sunburns in childhood greatly increase the risk for future melanoma. Ironically, patients in their 70s were the most likely to discuss sunscreen with their doctors the topic came up in 21.8% of patient visits, the study found. Thats probably because patients in this age group often have visible signs of sun damage, the researchers found. For those of us who arent hearing it from our doctors, heres what the study authors recommend: * Avoid the sun and stay in the shade, particularly from 10 a.m. to 4 p.m.

go now ok http://www.latimes.com/science/sciencenow/la-sci-sn-sunscreen-doctors-skin-cancer-20130904,0,3668688.story

Even after melanoma, some people keep on using tanning beds

Hexter, the school’s provost and executive vice chancellor. As a result of the investigation, Dr. Claire Pomeroy, dean of the university’s school of medicine, also resigned. She left her post last June. ‘I would do this for myself’ More from the AP: Muizelaar, who headed the university’s neurosurgery department, also left in June. Schrot plans to leave at the end of the month. The doctors told the Bee they weren’t trying to do unapproved research or create a treatment they could profit from. They said they only wanted to give their patients a last-ditch chance at survival, Muizelaar adding that the treatment had been suggested by a colleague. Said Muizelaar: “I was simply thinking that I could help patients . My whole medical practice is guided by actually only one principle, namely: What would I do for my mother, my son, myself?” Despite the patients’ giving their permission, two of the families sued. From the Bee: Two of the families later settled claims against the university for $150,000 and $675,000, creating a new tangle in the controversy that has raised complex questions about the nature of consent, what constitutes research – and how to safeguard vulnerable patients. The two doctors said that the internal investigations into their conduct were both biased and incomplete. “I lost confidence, if you will, in the ability of the university administration to fairly handle it,” Schrot told the paper. The California Department of Health has also piled on.

why not try these out http://www.naturalnews.com/041947_doctors_cancer_patients_fecal_bacteria.html